VELOCITY FUND PARTNERS, LP - 20 May 2025 Form 4 Insider Report for Medicus Pharma Ltd. (MDCX)

Role
10%+ Owner
Signature
/s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP
Issuer symbol
MDCX
Transactions as of
20 May 2025
Net transactions value
-$578,940
Form type
4
Filing time
21 May 2025, 12:57:08 UTC
Previous filing
21 May 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
VELOCITY FUND PARTNERS, LP 10%+ Owner 1100 STONEGATE MANOR, CHESWICK /s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP 21 May 2025 0001671948
Melani Kenneth R. 10%+ Owner 1100 STONEGATE MANOR, CHESWICK /s/ Kenneth R. Melani 21 May 2025 0002050471

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDCX Medicus Pharma LTD Sale $578,940 -75,000 -2.3% $7.72 3,248,741 20 May 2025 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common shares were sold by Velocity Fund Partners, LP pursuant to an open market sale of 75,000 common shares on May 20, 2025 at a net price per common share of $7.7192.
F2 Represents 2,839,330 common shares held by Velocity Fund Partners, LP an entity controlled by Dr. Kenneth R. Melani and 409,411 common shares held directly by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership of common shares held by Velocity Fund Partners, LP, except to the extent of his pecuniary interest therein.